North America Pregnancy Testing Market Overview
Pregnancy tests are tests used to detect the presence of reproductive hormones such as Follicle Stimulating Hormone or Luteinising Hormone. Fertility rapid test kits help to find the exact day of ovulation or confirm the presence of menopause in women where as they are used to detect the sperm count.
Rising demand for fast and self-contained tests, growing prevalence of infertility and gynecological disorders, accessibility of decentralized diagnostic tests over time-consuming laboratory tests are the major factors driving the growth of North America wearable medical devices market. Escalating first-time pregnancy age, technological advancements, and striking product features are also boosting the growth of Pregnancy and fertility devices market. However low adaptation rate and the high price of test kits are the key factors restraining the growth of the market
North America Pregnancy Testing Market Forecast Report (2018-2023)
North America Pregnancy Testing Market was worth USD $0.49 Billion in 2018 and estimated to reach USD $0.61 Billion by 2023 growing at a CAGR of 4.54%.
North America Pregnancy Testing Market Segmentation
The North America Market for Pregnancy testing is segmented into product type and test type and geography. On the basis of product the pregnancy testing market is segmented into Pregnancy Test Kits and Fertility Test Kits. Pregnancy test kits are further sub-segmented into Strips/Dip Sticks & Cards, Mid-Stream, Cassette and Digital Devices. Fertility test kits are further sub-segmented into Line Indicator Devices and Digital Devices. On the basis of test type the market is segmented into FSH Urine Test, Luteinizing Hormone (LH) Urine Test, Human Chorionic Gonadotropin (hCG) Hormone Blood Test and Human Chorionic Gonadotropin (hCG) Hormone Urine Test.
Geographically North America market for pregnancy testing is segmented into two regions namely the United States and Canada. United States is the largest market for Pregnancy testing accounting for a share of approximately XX%. Canada is estimated to be the fastest growing region during the forecast period.
Major Players:
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Product
5.1.1 Pregnancy Test Kits
5.1.1.1 Strips/Dip Sticks & Cards
5.1.1.2 Mid-Stream
5.1.1.3 Cassette
5.1.1.4 Digital Devices
5.1.2 Ovulation/Fertility Test Kits
5.1.2.1 Line Indicator Devices
5.1.2.2 Digital Devices
5.2 By Test Type
5.2.1 FSH Urine Test
5.2.2 Luteinizing Hormone (LH) Urine Test
5.2.3 Human Chorionic Gonadotropin (hCG) Hormone Blood Test
5.2.4 Human Chorionic Gonadotropin (hCG) Hormone Urine Test
6. Geographical Analysis
6.1 Introduction
6.2 United States
6.3 Canada
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Alere Inc
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Quidel Corporation
8.3 Prestige Brands Holdings
8.4 Church & Dwight Co
8.5 bioMérieux SA
8.6 Geratherm Medical AG
8.7 Germaine Laboratories
8.8 Abbott Laboratories
8.9 Kent Pharmaceuticals
8.10 Rite-Aid
8.11 Procter & Gamble Co.
8.12 DCC Plc.
8.13 Swiss Precision Diagnostics GmbH
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
